ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
Dow Jones
42.706,56
-0,06%
Euro vs US Dollar
1,03846
0,77%
Bitcoin
102.219,85
3,96%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Harmony Biosciences Holdings Inc (HRMY) Börsenkurse

Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc (HRMY)

NASDAQ
34,50
-0,28
(-0,81%)
Beim Schlusskurs: 07 Januar 10:00PM
Verzögert um 15 Minuten
34,50
0,00
( 0,00% )
Nach Börsenschluss: 10:00PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
34,50
Gebot
34,15
Fragen
34,92
Volumen
375.312
34,21 Tagesbereich 35,03
28,14 52-Wochen-Bereich 41,61
Marktkapitalisierung
1,968B
Handelsende
34,78
Handelsbeginn
34,88
Letzte Trade
4115
@
34.5
(priorref)
Letzter Handelszeitpunkt
23:14:34
Finanzvolumen
US$ 13.002.495
VWAP
34,6445
Durchschnittliches Volumen (3 Mio.)
747.819
Ausgegebene Aktien
57.031.297
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
15,27
Gewinn pro Aktie (EPS)
2,26
Erlöse
582,02M
Nettogewinn
128,85M

Über Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.harmonybiosciences.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Harmony Biosciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HRMY. The last closing price for Harmony Biosciences was US$34,78. Over the last year, Harmony Biosciences shares have traded in a share price range of US$ 28,14 to US$ 41,61.

Harmony Biosciences currently has 57.031.297 shares in issue. The market capitalisation of Harmony Biosciences is US$1,98 billion. Harmony Biosciences has a price to earnings ratio (PE ratio) of 15.27.

HRMY Neueste Nachrichten

Weitere Nachrichten

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa., Dec. 18, 2024 PLYMOUTH MEETING, Pa., Dec. 18, 2024 /PRNewswire/ -- Harmony...

18 Dezember 2024
PR Newswire (US)

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT PR Newswire PLYMOUTH MEETING, Pa., Dec. 3, 2024 PLYMOUTH MEETING, Pa., Dec. 3, 2024 /PRNewswire/ -- Harmony...

03 Dezember 2024
PR Newswire (US)

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES PR Newswire PLYMOUTH MEETING, Pa., Nov. 21, 2024 PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ -- Harmony Biosciences...

21 November 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

05 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

01 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Oktober 2024
Edgar (US Regulatory)

Form 424B7 - Prospectus [Rule 424(b)(7)]

31 Oktober 2024
Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 30, 2024 PLYMOUTH MEETING, Pa., Oct. 30...

31 Oktober 2024
PR Newswire (US)

Form 424B7 - Prospectus [Rule 424(b)(7)]

29 Oktober 2024
Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 29, 2024 PLYMOUTH MEETING...

29 Oktober 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.541.5901060070733.9635.6733.362934744634.52964438CS
40.51.470588235293435.6731.61554457733.80550939CS
12-0.43-1.2310334955634.9341.6131.0574781934.03542687CS
262.57.81253241.6130.1757450134.6938596CS
521.895.7957681692732.6141.6128.1447496833.25615282CS
156-6.06-14.940828402440.5662.08518.611255276638.06852694CS
260-2-5.4794520547936.562.08518.611246459037.74870499CS

HRMY - Frequently Asked Questions (FAQ)

What is the current Harmony Biosciences share price?
The current share price of Harmony Biosciences is US$ 34,50
How many Harmony Biosciences shares are in issue?
Harmony Biosciences has 57.031.297 shares in issue
What is the market cap of Harmony Biosciences?
The market capitalisation of Harmony Biosciences is USD 1,98B
What is the 1 year trading range for Harmony Biosciences share price?
Harmony Biosciences has traded in the range of US$ 28,14 to US$ 41,61 during the past year
What is the PE ratio of Harmony Biosciences?
The price to earnings ratio of Harmony Biosciences is 15,27
What is the cash to sales ratio of Harmony Biosciences?
The cash to sales ratio of Harmony Biosciences is 3,38
What is the reporting currency for Harmony Biosciences?
Harmony Biosciences reports financial results in USD
What is the latest annual turnover for Harmony Biosciences?
The latest annual turnover of Harmony Biosciences is USD 582,02M
What is the latest annual profit for Harmony Biosciences?
The latest annual profit of Harmony Biosciences is USD 128,85M
What is the registered address of Harmony Biosciences?
The registered address for Harmony Biosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Harmony Biosciences website address?
The website address for Harmony Biosciences is www.harmonybiosciences.com
Which industry sector does Harmony Biosciences operate in?
Harmony Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MSAIMultiSensor AI Holdings Inc
US$ 2,85
(42,50%)
2,56M
MCVTMill City Ventures III Ltd
US$ 3,04
(34,51%)
101,81k
XTIAXTI Aerospace Inc
US$ 0,1168
(32,73%)
377,71M
CDTConduit Pharmaceuticals Inc
US$ 0,0938
(29,74%)
17,08M
QRTEBQurate Retail Inc
US$ 3,13
(22,27%)
103
ENVBEnveric Biosciences Inc
US$ 0,3388
(-19,81%)
480,17k
AMSTAmesite Inc
US$ 3,45
(-14,81%)
60,67k
WATTEnergous Corporation
US$ 1,05
(-14,63%)
631,72k
SLRNACELYRIN Inc
US$ 2,9799
(-14,62%)
506,19k
ACXPAcurx Pharmaceuticals Inc
US$ 0,9401
(-13,75%)
166,52k
XTIAXTI Aerospace Inc
US$ 0,1168
(32,73%)
377,71M
SVMHSRIVARU Holding Ltd
US$ 0,0516
(11,45%)
30,11M
CRKNCrown Electrokinetics Corporation
US$ 0,1428
(7,37%)
29,76M
CEROCERo Therapeutics Holdings Inc
US$ 0,0468
(10,64%)
19,12M
CDTConduit Pharmaceuticals Inc
US$ 0,0938
(29,74%)
17,08M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
HRMY
Harmony Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten